Novartis Cosentyx meets primary endpoint in patients with axial spondyloarthritis Medical Dialogues Bureau17 Sept 2019 9:00 AM ISTNovartis Cosentyx is backed by clinical evidence, including 5-year data across three indications of psoriasis, PsA and AS as well as data from...
AstraZeneca Farxiga gets USFDA fast track designation for heart failure Farhat Nasim16 Sept 2019 9:32 AM ISTThe grant comes after AstraZeneca made strides last month towards its goal of adding heart failure to the conditions that can be treated by Farxiga,...
Cadila Pharma bags ObserveNow Future of Workplace Award among 50 others in fray Medical Dialogues Bureau16 Sept 2019 9:25 AM IST"The selection was made on the basis of the technologies used in the company, HR policies, and initiatives taken to make the organization an...
Lundbeck to acquire migraine drugmaker Alder BioPharma for USD 1.95 billion Farhat Nasim16 Sept 2019 9:20 AM ISTNew Delhi: Lundbeck and Alder BioPharmaceuticals recently announced a definitive agreement for Lundbeck to acquire Alder. The transaction is valued...
Biogen Alzheimer drug Aducanumab failure wipes USD 18 billion from market value Medical Dialogues Bureau16 Sept 2019 9:00 AM ISTAducanumab's failure wiped out more than $18 billion of Biogen Inc's market value, as investors were betting on the treatment to buoy the drugmaker,...
Purdue Pharma files for bankruptcy protection as part of opioid settlement Medical Dialogues Bureau16 Sept 2019 8:59 AM ISTPurdue Pharma's board met on Sunday evening to approve the long-expected bankruptcy filing, which the company is pursuing to restructure under terms...
Unichem Labs receives zero USFDA observations for Roha facility Medical Dialogues Bureau15 Sept 2019 10:00 AM ISTThe inspection of the active pharmaceutical ingredients facility at Roha was conducted from September 9 to September 12 2019 by the United States Food...
GSK gets USFDA nod for Nucala, only biologic to treat eosinophilic asthma in age group 6-11 year Medical Dialogues Bureau15 Sept 2019 9:50 AM ISTNucala is the only targeted biologic to be approved for the condition in the six to 11-year age group in the US, said GSK.New Delhi: GlaxoSmithKline...
Granules India gets EIR from USFDA for Paracetamol, Metformin API manufacturing plant Medical Dialogues Bureau15 Sept 2019 9:30 AM ISTBonthapally facility is one of the world’s largest single-site Paracetamol API manufacturing plant by volume. Along with Paracetamol APIs, the...
Medical Devices Sector: CII seeks Government to bring trade margin rationalisation Medical Dialogues Bureau15 Sept 2019 9:15 AM ISTThe government is planning to come out with a Medical Devices Act which is going to be put in public domain shortly, Baid said adding, "The medical...
Everstone-backed Everlife names Raman Gandotra as new CEO Medical Dialogues Bureau15 Sept 2019 9:00 AM ISTPrior to joining Everlife, Raman Gandotra was leading the India and South-East Asia business of Smith & Nephew, Baxter and Allergan.New Delhi:...
UK drug regulator MHRA reinstates full GMP status to Indoco Goa Plant I Medical Dialogues Bureau14 Sept 2019 11:52 AM ISTUK-MHRA conducted a ‘Focused Audit’ in October 2018 and GMP audit in May 2019. These audits were completed with no Critical Observations and Indoco...
